原中国银行保险监督管理委员会党委委员、副主席梁涛针对"十五五"时期保险业的使命和担当发表了自己的看法。梁涛认为，保险业应该发挥好耐心资本作 用。精准适配科技企业全生命周期的资本需求，可以设立专项的科技创新投资基金，重点投向初创期、成长期的"专精特新小巨人"企业，聚焦核心技术攻 关、重大成果转化等关键环节，提供长期股权融资支持。 可以深入参与风险投资与私募股权，通过直投、跟投的方式嵌入科技产业链价值培育环节，助力企业突破产能扩张与市场拓展的资金瓶颈，也可以创新保险 加股权投资的联动模式，对投保科技保险的优质企业给予优先投资权，形成保险兜底风险、资本助推成长的良性循环。还可以拓宽债务融资支持的渠道，即 投资科技创新公司的债券、绿色科技债券等产品，为企业的规模化生产提供多元化资金供给。 12月26日，由金融界主办的"启航·2025金融年会"在北京举行。本次年会以"新开局、新动能、新征程"为主题，来自政、商、学、研等领域的100多位嘉宾、 500余家金融机构和上市公司齐聚一堂，共赴这场思想盛宴。 梁涛还提到，保险业还要做好五篇大文章，着力提供高质量服务，助力经济实现质的有效提升和量的合理增长。从高效服务现代化产业体系 ...

Group 1 - Lanzhou Lanshi Heavy Equipment Co., Ltd. (referred to as "Lanshi Heavy Equipment") announced that its subsidiaries, Lanzhou Lanshi Heat Exchange Equipment Co., Ltd. (referred to as "Heat Exchange Company") and Qingdao Lanshi Heavy Machinery Equipment Co., Ltd. (referred to as "Qingdao Company"), have obtained important qualification recognitions [2] - The Heat Exchange Company has been recognized as a national-level "specialized, refined, distinctive, and innovative" small giant enterprise, which is part of the seventh batch of such enterprises in Gansu Province [2] - The Heat Exchange Company, established in 1965, is the only state-owned enterprise in the field of plate heat exchangers and has a leading position in technology, equipment level, and production scale in the domestic industry [2] Group 2 - The Heat Exchange Company has developed over 100 series of products, including detachable plate heat exchangers and welded plate heat exchangers, achieving domestic leading and international advanced levels in several areas [3] - Qingdao Company has been recognized as a high-tech enterprise, allowing it to enjoy preferential tax policies for three consecutive years, with a corporate income tax rate of 15% [3] - Qingdao Company has also been included in the list of "Shandong Province Manufacturing Single Champion Enterprises," which recognizes its excellence in manufacturing [3] Group 3 - Qingdao Company focuses on high-end equipment manufacturing for refining and chemical industries, providing core equipment with high technical content and added value [4] - The recognition of the subsidiaries as specialized, high-tech, and manufacturing champions reflects their comprehensive development strength in R&D, technological innovation, and product services [4] - This recognition is expected to enhance Lanshi Heavy Equipment's competitiveness and influence in the energy-saving and traditional energy chemical equipment sectors [4]

12月24日，有一只新股上市，为科创板的健信超导（688805.SH）。该公司成立于2013年12月11日，主 要从事医用磁共振成像（MRI）设备核心部件的研发、生产和销售，主要产品包括超导磁体、永磁体和 梯度线圈，这三大类部件占MRI设备核心部件成本的比例在50%左右。 打新早知道 Est Un Descrip | | | 今日上市 | | | --- | --- | --- | --- | | | 688805.SH 健信超导 | | | | 发行价(元/股) | 机构报价(元/股) | 市值(亿元) | 所属行业 | | 18.58 | 18.89 | 31.15 | 医疗仪器设备及器 | | | | | 械制造 | | 发行市盈率 | 行业市盈率 | 可比公司 | 可比公司动态市盈率 | | | | 联影医疗 | 60.39 | | 61.97 | 31.79 | 辰光医疗 | 亏损 | | | | 奕瑞科技 | 40.38 | | | 业绩情况 | | | | 5.0 4.5 | | | 50% | | 4.0 | | | 40% | | 3.5 3.0 - | | | 30% | 不过，当前健信超 ...

瑞财经 刘治颖 12月17日，森泰英格（成都）数控刀具股份有限公司（以下简称：森泰英格）在四川证监局完成IPO辅导备案，拟北交所上市，辅导机构为 开源证券。 据瑞财社查阅，森泰英格曾于2020年11月申报科创板IPO并获上交所受理，保荐机构为东莞证券。2021年3月12日，森泰英格申请撤回发行上市申请文件； 2021年3月15日，上交所终止其发行上市审核。 森泰英格成立于1997年7月，主要从事数控机床核心附件和数控刀具的研发、生产和销售业务，是国家级专精特新"小巨人"企业。公司于2025年10月挂牌新 三板。 公司产品品类齐全，涵盖了工具系统及附件、可转位刀具、刀片、超硬刀具、合金刀具等高端数控刀具，以及液压夹具和机械夹具等精密夹具。产品广泛应 用于汽车、航空航天、工程机械、能源装备、通用机械、模具制造、轨道交通、石油化工、3C等领域。 2023年、2024年，森泰英格营业收入分别为2.97亿元、3.3亿元；净利润4772.27万元、3249.39万元；毛利率分别为43.1%、37.49%。 刘敏系夏永奎的配偶，其直接持有公司363.3万股股份，占公司股份的6.56%。自股份公司设立以来，夏永奎一直担任公司 ...

经济导报记者 杨佳琪 12月18日，山东海奥斯生物科技股份有限公司（下称"海奥斯"）披露公开发行股票并在北交所上市辅导备案公告。 经济导报记者注意到，其在12月15日当天终止前次辅导后，宣布更换辅导券商，并火速重启了上市。 公告显示，12月15日，海奥斯与招商证券股份有限公司签订辅导协议，并于同日向山东证监局提交了辅导备案材料。12月18日，山东证监局受理公司的辅 导备案申请。 据公开信息，2023年10月，海奥斯在山东证监局进行了辅导备案，拟冲击深交所主板上市。 据了解，海奥斯主要产品为胶原蛋白肠衣。其除与双汇集团、金锣集团、龙大美食、安井食品、惠发食品、青岛正大等国内肉制品龙头企业建立了长期、 稳定的合作关系之外，也成为国内少数拥有稳定国际市场的胶原蛋白肠衣出口企业。 财务数据显示，近期海奥斯业绩有所波动。2024年，该公司实现营业收入42348.51万元，同比下降5.60%；归母净利润为10977.26万元，同比下降4.33%； 2025年上半年，该公司实现营业收入20075.13万元，同比下降1.21%；归母净利润为4573.55万元，同比下降17.59%。 此外，海奥斯收入增长主要依靠单一产品。20 ...

Group 1 - The company, Quanxin Co., Ltd. (300447.SZ), is recognized as a "Little Giant" enterprise by the Ministry of Industry and Information Technology, indicating its specialization and innovation in its field [1]

海森药业（001367）(001367.SZ)公告，公司通过第七批专精特新"小巨人"企业认定。 ...

Core Viewpoint - Wuxi Chuangda New Materials Co., Ltd. is set to hold its IPO meeting at the Beijing Stock Exchange on December 18, 2025, after being accepted for listing on June 30, 2023 [1][4]. Financial Performance - The company reported revenues of 311 million yuan, 345 million yuan, 419 million yuan, and 211 million yuan for the years 2022, 2023, 2024, and the first half of 2025, respectively, showing consistent growth [4]. - Net profits for the same periods were 22.73 million yuan, 51.47 million yuan, 61.22 million yuan, and 33.18 million yuan, indicating a positive trend [4]. - For the first nine months of 2025, the company achieved revenues of 322 million yuan, an increase of 8.84% year-on-year, and net profits of 52.94 million yuan, up 22.20% from the previous year [5]. Business Overview - The main business of the company includes the research, production, and sales of high-performance thermosetting composite materials, with key products such as epoxy molding compounds and conductive silver paste, primarily used in semiconductor and automotive electronics packaging [4]. - The company was listed as a national-level specialized and innovative "little giant" enterprise in October 2025 [4]. Financial Metrics - Total assets as of June 30, 2025, were approximately 644.27 million yuan, with total equity of about 564.70 million yuan [5]. - The company's debt-to-asset ratio was 9.58% as of June 30, 2025, showing a decrease from previous years [5]. - The gross profit margin improved to 33.08% in the first half of 2025, compared to 24.80% in 2022 [5]. Risks and Concerns - The company highlighted risks related to macroeconomic conditions, market demand fluctuations, and competition, which could impact future performance [6]. - There are concerns regarding related party transactions and accounts receivable, with significant reliance on a related company for procurement [7][8]. - The company reported a total accounts receivable balance of 194 million yuan, 223 million yuan, 242 million yuan, and 247 million yuan for the years ending 2022, 2023, 2024, and mid-2025, respectively, which poses a risk of bad debts [10].

Core Viewpoint - The company Chuangyuan Xinke plans to acquire 100% equity of Shanghai Weiyu Tiandao Technology Co., Ltd. for a total transaction price of 886 million yuan, marking the second significant asset merger and acquisition case on the Beijing Stock Exchange since the release of the "Merger and Acquisition Six Guidelines" [2] Group 1: Transaction Details - The acquisition will be financed through a combination of share issuance and cash payment, with the final transaction price based on an evaluation report from a qualified asset appraisal agency [2] - The payment structure includes 755.13 million yuan in shares and 131.17 million yuan in cash, with shares issued at a price of 18.88 yuan per share, representing 21.88% of the company's total share capital post-transaction [2] - The company plans to raise up to 140 million yuan in supporting funds to cover cash payments, intermediary fees, and related taxes [2] Group 2: Company Profiles - Chuangyuan Xinke, established in 2005, specializes in wireless communication testing and optimization, focusing on 5G/6G communication, vehicle networking, and satellite internet testing [3] - Weiyu Tiandao, founded in 2015, excels in satellite navigation simulation testing, holding 53 patents, including 46 invention patents, and demonstrates strong profitability and industry competitiveness [3] Group 3: Strategic Implications - Post-acquisition, Weiyu Tiandao will become a wholly-owned subsidiary of Chuangyuan Xinke, enabling the integration of communication and navigation testing systems to provide comprehensive testing solutions [4] - The transaction is expected to enhance the company's operational capabilities and core competitiveness, fostering high-quality development and injecting new vitality into the communication and navigation positioning industry [4] Group 4: Market Reaction - On December 11, Chuangyuan Xinke's stock price rose by 7.61%, with a cumulative increase of over 87% for the year [5]

Core Viewpoint - Jiangsu Suxun New Materials Technology Co., Ltd. has completed its listing guidance work, with Open Source Securities as the guiding institution, indicating the company's readiness for public offering and growth potential in the new materials sector [2] Group 1: Company Overview - Suxun New Materials was established in April 2009 and focuses on the research, production, and sales of various types of steel thin plates and special steel wires [2] - The company is recognized as a high-tech enterprise and a "little giant" enterprise by the Ministry of Industry and Information Technology, specializing in products such as chrome-plated thin plates, tin-plated thin plates, stainless steel thin plates, and food-grade thermal laminated iron [2] - Suxun New Materials is the first domestic manufacturer to provide food-grade stainless steel packaging materials on a large scale, maintaining the highest market share in chrome-plated thin steel belt products from 2020 to 2024 [2] Group 2: Financial Performance - In the first half of 2025, Suxun New Materials achieved operating revenue of 1.554 billion yuan, representing a year-on-year increase of 8.24% [3][4] - The net profit attributable to the parent company was 141 million yuan, showing a significant growth of 35.63% compared to the previous year [3][4] - As of June 30, 2025, the company's total assets amounted to 1.981 billion yuan, with shareholders' equity of 1.068 billion yuan and a debt-to-asset ratio of 45.86% [3] Group 3: Profitability Metrics - The gross profit margin for the reporting period was 13.80%, an increase from 10.14% in the previous year [4] - The weighted average return on equity was 13.51%, up from 12.87% year-on-year [4] - Basic earnings per share reached 2.76 yuan, reflecting a 35.63% increase compared to the same period last year [4] Group 4: Shareholding Structure - Li Longlai, the chairman and general manager, holds 20.0396 million shares, accounting for 39.19% of the total shares [3] - Li Kang, the vice general manager and Li Longlai's son, holds 11.725 million shares, representing 22.93% of the total shares [3] - Huang Xueya, Li Longlai's wife and a board member, holds 4.777 million shares, making up 9.34% of the total shares [3]